Zurich Cantonal Bank
PRQR icon

Zurich Cantonal Bank’s ProQR Therapeutics PRQR Stock Holding History

Zurich Cantonal Bank’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,819
Closed -$3K – 2891
2022
Q3 		$3K Hold
3,819
– – ﹤0.01% 2896
2022
Q2 		$3K Hold
3,819
– – ﹤0.01% 2883
2022
Q1 		$3K Buy
+3,819
New +$12.8K ﹤0.01% 2717
2019
Q4 		– Sell
-4,426
Closed -$25K – 2615
2019
Q3 		$25K Hold
4,426
– – ﹤0.01% 2381
2019
Q2 		$40K Buy
4,426
+1,072
+32% +$12.6K ﹤0.01% 2201
2019
Q1 		$47K Hold
3,354
– – ﹤0.01% 2054
2018
Q4 		$53K Buy
+3,354
New +$61.6K ﹤0.01% 1997

Other funds holding PRQR

PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Zurich Cantonal Bank's PRQR Position: Q4 2022 in Review

Zurich Cantonal Bank sold out of ProQR Therapeutics (PRQR) in Q4 2022, closing a stake of 3,819 shares — an estimated $3K sold.

Zurich Cantonal Bank first reported a position in PRQR in Q4 2018 and held it in 7 quarters. The position peaked at $53K in Q4 2018. 46 funds tracked by Wall St. Rank hold PRQR as of Q4 2022.

  • Zurich Cantonal Bank reported no remaining ProQR Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 3,819 ProQR Therapeutics shares in Q4 2022, an estimated $3K.
  • Zurich Cantonal Bank first reported a position in ProQR Therapeutics in Q4 2018 and held it in 7 quarters.
  • Zurich Cantonal Bank's ProQR Therapeutics position peaked at $53K in Q4 2018.
  • 46 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q4 2022.

Based on Zurich Cantonal Bank's 13F filing for Q4 2022, filed 1 Feb 2023.